Chongqing Chen'an Biopharma

[Company Profile]
Chongqing Chen'an Biopharmaceutical Co., Ltd. is a high-tech enterprise focusing on the research, development and production of therapeutic drugs for chronic diseases such as diabetes and obesity. It is a controlled subsidiary of Chongqing Zhifei Biological Products Co., Ltd.
[R&D Platform Introduction]
The R&D center includes a 2,000-square-meter clean pilot production workshop and a 1,000-square-meter quality inspection center. The main R&D equipment and instruments are from well-known domestic and international companies, capable of meeting the needs for new drug R&D, pilot testing, preclinical and clinical research.
[Industrialization Platform Introduction]
The industrialization project covers an area of approximately 230 mu, constructed in three phases, with a total construction area of 130,000 square meters and a total investment of approximately 3 billion yuan. It is equipped with two API production workshops with an 8-ton fermentation scale, as well as a formulation filling workshop and quality center that meet international standards. In the future, it will achieve an annual production of 30 million insulin analog finished products, and after reaching full capacity, the estimated annual output value will reach approximately 3 billion yuan. According to the company's development plan, all three phases are expected to be completed within the next 10 years, with a total output value exceeding 10 billion yuan.